Details for New Drug Application (NDA): 208170
✉ Email this page to a colleague
The generic ingredient in CYCLOBENZAPRINE HYDROCHLORIDE is cyclobenzaprine hydrochloride. There are sixteen drug master file entries for this compound. Fifty-eight suppliers are listed for this compound. Additional details are available on the cyclobenzaprine hydrochloride profile page.
Summary for 208170
Tradename: | CYCLOBENZAPRINE HYDROCHLORIDE |
Applicant: | Rubicon |
Ingredient: | cyclobenzaprine hydrochloride |
Patents: | 0 |
Pharmacology for NDA: 208170
Physiological Effect | Centrally-mediated Muscle Relaxation |
Suppliers and Packaging for NDA: 208170
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
CYCLOBENZAPRINE HYDROCHLORIDE | cyclobenzaprine hydrochloride | TABLET;ORAL | 208170 | ANDA | medsource pharmaceuticals | 45865-962 | 45865-962-20 | 20 TABLET, FILM COATED in 1 BOTTLE (45865-962-20) |
CYCLOBENZAPRINE HYDROCHLORIDE | cyclobenzaprine hydrochloride | TABLET;ORAL | 208170 | ANDA | medsource pharmaceuticals | 45865-962 | 45865-962-30 | 30 TABLET, FILM COATED in 1 BOTTLE (45865-962-30) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 5MG | ||||
Approval Date: | May 31, 2017 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 7.5MG | ||||
Approval Date: | May 31, 2017 | TE: | AB | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 10MG | ||||
Approval Date: | May 31, 2017 | TE: | AB | RLD: | No |
Complete Access Available with Subscription